Myeloid-Derived Suppressor Cells May Predict the Occurrence of Postoperative Complications in Colorectal Cancer Patients-a Pilot Study

Joanna Rogala; Izabela Siemińska; Jarek Baran; Mateusz Rubinkiewicz; Justyna Zybaczyńska; Antoni M Szczepanik; Radoslaw Pach

doi:10.1007/s11605-022-05364-3

Myeloid-Derived Suppressor Cells May Predict the Occurrence of Postoperative Complications in Colorectal Cancer Patients-a Pilot Study

J Gastrointest Surg. 2022 Nov;26(11):2354-2357. doi: 10.1007/s11605-022-05364-3. Epub 2022 Jun 1.

Authors

Joanna Rogala¹, Izabela Siemińska², Jarek Baran², Mateusz Rubinkiewicz³, Justyna Zybaczyńska⁴, Antoni M Szczepanik¹, Radoslaw Pach⁵

Affiliations

¹ First Department of Surgery, Faculty of Medicine, Jagiellonian University Medical College, 2 Jakubowskiego Street, 30-688, Krakow, Poland.
² Department of Clinical Immunology, Jagiellonian University Medical College, Krakow, Poland.
³ Second Department of Surgery, Jagiellonian University Medical College, Krakow, Poland.
⁴ Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
⁵ First Department of Surgery, Faculty of Medicine, Jagiellonian University Medical College, 2 Jakubowskiego Street, 30-688, Krakow, Poland. radoslaw.pach@uj.edu.pl.

PMID: 35650461
DOI: 10.1007/s11605-022-05364-3

No abstract available

Keywords: Clavien-Dindo; Colorectal cancer; Early MDSC; Monocytic MDSC; Myeloid-derived suppressor cells; Polymorphonuclear MDSC; Postoperative complications.

MeSH terms

Colorectal Neoplasms* / surgery
Humans
Monocytes
Myeloid-Derived Suppressor Cells*
Pilot Projects
Postoperative Complications / etiology